天然产物研究与开发 ›› 2016, Vol. 28 ›› Issue (12): 1971-1977.doi: 10.16333/j.1001-6880.2016.12.021

• 开发研究 • 上一篇    下一篇

热感赛比斯坦颗粒毒理学实验研究

李慧芳1,庞克坚2,唐辉1*,张博1,刘新豫1   

  1. 1石河子大学药学院新疆特种植物药资源教育部重点实验室,石河子832000;2和田维吾尔药业有限责任公司,和田 848200
  • 出版日期:2016-12-31 发布日期:2017-03-31

Toxicology of Regansaibisitan Particles

LI Hui-fang1,PANG Ke-jian2,TANG Hui 1*,ZHANG Bo1,LIU Xin-yu1   

  1. 1 Modernization of Traditional Chinese Medicine,Ministry of Education,School of Pharmacy,Shihezi University, Shihezi 832000,China;2Xinjiang Uygur Pharmaceutical Limited Liablity Company,Hetian 848200,China
  • Online:2016-12-31 Published:2017-03-31

摘要: 观察热感赛比斯坦颗粒对小鼠的急性和大鼠长期毒性反应。将热感赛比斯坦颗粒生药浸膏液干燥,粉碎,以最大浓度及小鼠最大给药体积对小鼠灌胃,进行最大耐受量试验,观察两周之内出现的急性毒性反应。采用SD大鼠分别给予37.50 g/(kg·d)、12.50 g/(kg·d)、3.75 g/(kg·d)药物灌胃,空白组给予同等体积的蒸馏水,进行长期毒性试验。在给药30 d、停药15 d测定生化、血象指标、脏器系数和各主要脏器病理切片。急性毒性试验测得小鼠最大耐受量为299.70 g/kg,无死亡现象,解剖后发现小鼠各主要脏器无肉眼可见病变。长期毒性试验给药及恢复期间各组大鼠体重无统计学差异。血液学、血生化及脏器系数检查,给药组与对照组之间个别指标有差异,无毒性意义。主要脏器的病理组织学检查,未见明显病理改变。本研究证明热感赛比斯坦颗粒临床成人拟用给药剂量远低于其毒性剂量,安全性良好。

关键词: 热感赛比斯坦颗粒, 急性毒性, 最大耐受量, 长期毒性

Abstract: The purpose of this study was to investigate the acute and chronic toxicity of the Regansaibisitan particles.In order to explore the acute toxic reaction of Regansaibisitan particles in two weeks,the maximum tolerable test was performed as follows:the extract of Regansaibisitan particles,as tested drug,was dried,crushed,and then was given to mice by gavage with two dosages (the maximum volume of mice and the maximum concentration of Regansaibisitan particles in mice).In addition,SD rats were randomized into four groups:three testing groups which were treated with 37.50 g/(kg·d),12.50 g/(kg·d) and 3.75 g/(kg·d) of Regansaibisitan particles extract,respectively,and one blank control group which was treated with the same volume of distilled water.Subsequently,at 30 days of medication and 15 days of drug withdrawal,the hemogram index,biochemical index,organ coefficient and pathological sections of main organs were detected respectively.As a result,the maximum tolerable dose of mice to the Regansaibisitan particles extract was 299.70 g/kg.In addition,there was no death,no visible lesion of the main organs which were observed via dissection method,and no statistically significant difference on the weight of the rats during the whole experimental process.As for hemogram index,biochemical index and organ coefficient,there were some differences between the testing groups and the control group,but no toxic significance.In terms of pathological sections of major organs,no obvious pathological change was observed.In conclusion,this study demonstrated that clinical dose of Regansaibisitan particles was far less than its toxic dose,illustrating it had reliable safety.

Key words: Regansaibisitan particles, acute toxicity, maximum tolerated dose, chronic toxicity

中图分类号: 

R29